Go Pro
→ Jeff Brown and Marc Chaikin's latest AI prediction explained (From Brownstone Research) (Ad)tc pixel Free NXGLW Stock Alerts

NEXGEL (NXGLW) Competitors

NEXGEL logo
$0.03 +0.00 (+15.64%)
As of 04:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

NXGLW vs. DRTSW, ANZUW, HSCSW, BEATW, and LUCYW

Should you buy NEXGEL stock or one of its competitors? MarketBeat compares NEXGEL with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with NEXGEL include Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Heart Test Laboratories (HSCSW), HeartBeam (BEATW), and Innovative Eyewear (LUCYW). These companies are all part of the "medical equipment" industry.

How does NEXGEL compare to Alpha Tau Medical?

NEXGEL (NASDAQ:NXGLW) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, analyst recommendations, risk, valuation, institutional ownership, earnings and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NEXGEL$11.27MN/AN/AN/AN/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
NEXGELN/A N/A N/A
Alpha Tau Medical N/A N/A N/A

In the previous week, NEXGEL had 1 more articles in the media than Alpha Tau Medical. MarketBeat recorded 2 mentions for NEXGEL and 1 mentions for Alpha Tau Medical. Alpha Tau Medical's average media sentiment score of 1.34 beat NEXGEL's score of 0.43 indicating that Alpha Tau Medical is being referred to more favorably in the news media.

Company Overall Sentiment
NEXGEL Neutral
Alpha Tau Medical Positive

Summary

NEXGEL beats Alpha Tau Medical on 2 of the 3 factors compared between the two stocks.

How does NEXGEL compare to Anzu Special Acquisition Corp I?

NEXGEL (NASDAQ:NXGLW) and Anzu Special Acquisition Corp I (NASDAQ:ANZUW) are both medical equipment companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, media sentiment, valuation and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NEXGEL$11.27MN/AN/AN/AN/A
Anzu Special Acquisition Corp IN/AN/AN/AN/AN/A

In the previous week, NEXGEL had 2 more articles in the media than Anzu Special Acquisition Corp I. MarketBeat recorded 2 mentions for NEXGEL and 0 mentions for Anzu Special Acquisition Corp I. NEXGEL's average media sentiment score of 0.43 beat Anzu Special Acquisition Corp I's score of 0.00 indicating that NEXGEL is being referred to more favorably in the media.

Company Overall Sentiment
NEXGEL Neutral
Anzu Special Acquisition Corp I Neutral

Company Net Margins Return on Equity Return on Assets
NEXGELN/A N/A N/A
Anzu Special Acquisition Corp I N/A N/A N/A

Summary

NEXGEL beats Anzu Special Acquisition Corp I on 3 of the 3 factors compared between the two stocks.

How does NEXGEL compare to Heart Test Laboratories?

Heart Test Laboratories (NASDAQ:HSCSW) and NEXGEL (NASDAQ:NXGLW) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, risk, analyst recommendations, earnings, dividends and institutional ownership.

Company Net Margins Return on Equity Return on Assets
Heart Test LaboratoriesN/A N/A N/A
NEXGEL N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Heart Test Laboratories$8.67KN/AN/AN/AN/A
NEXGEL$11.27MN/AN/AN/AN/A

In the previous week, Heart Test Laboratories had 1 more articles in the media than NEXGEL. MarketBeat recorded 3 mentions for Heart Test Laboratories and 2 mentions for NEXGEL. Heart Test Laboratories' average media sentiment score of 0.67 beat NEXGEL's score of 0.43 indicating that Heart Test Laboratories is being referred to more favorably in the media.

Company Overall Sentiment
Heart Test Laboratories Positive
NEXGEL Neutral

Summary

Heart Test Laboratories beats NEXGEL on 2 of the 3 factors compared between the two stocks.

How does NEXGEL compare to HeartBeam?

NEXGEL (NASDAQ:NXGLW) and HeartBeam (NASDAQ:BEATW) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, risk, valuation and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NEXGEL$11.27MN/AN/AN/AN/A
HeartBeamN/AN/AN/AN/AN/A

In the previous week, NEXGEL and NEXGEL both had 2 articles in the media. HeartBeam's average media sentiment score of 1.44 beat NEXGEL's score of 0.43 indicating that HeartBeam is being referred to more favorably in the news media.

Company Overall Sentiment
NEXGEL Neutral
HeartBeam Positive

Company Net Margins Return on Equity Return on Assets
NEXGELN/A N/A N/A
HeartBeam N/A N/A N/A

Summary

NEXGEL and HeartBeam tied by winning 1 of the 2 factors compared between the two stocks.

How does NEXGEL compare to Innovative Eyewear?

Innovative Eyewear (NASDAQ:LUCYW) and NEXGEL (NASDAQ:NXGLW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, media sentiment, risk, valuation, dividends and earnings.

In the previous week, Innovative Eyewear had 2 more articles in the media than NEXGEL. MarketBeat recorded 4 mentions for Innovative Eyewear and 2 mentions for NEXGEL. Innovative Eyewear's average media sentiment score of 1.15 beat NEXGEL's score of 0.43 indicating that Innovative Eyewear is being referred to more favorably in the media.

Company Overall Sentiment
Innovative Eyewear Positive
NEXGEL Neutral

Company Net Margins Return on Equity Return on Assets
Innovative EyewearN/A N/A N/A
NEXGEL N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innovative Eyewear$2.98MN/AN/AN/AN/A
NEXGEL$11.27MN/AN/AN/AN/A

Summary

Innovative Eyewear beats NEXGEL on 2 of the 3 factors compared between the two stocks.

Get NEXGEL News Delivered to You Automatically

Sign up to receive the latest news and ratings for NXGLW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NXGLW vs. The Competition

Export
MetricNEXGELMedical Instruments & Supplies IndustryMedical SectorNASDAQ Exchange
Market CapN/A$3.03B$6.85B$12.44B
Dividend YieldN/A1.92%2.68%8.43%
P/E RatioN/A17.4927.0424.38
Price / SalesN/A105.52524.2593.48
Price / CashN/A146.5448.5959.36
Price / BookN/A2.5110.806.33
Net IncomeN/A$99.80M$3.59B$331.02M
7 Day PerformanceN/A0.08%-2.24%-1.09%
1 Month PerformanceN/A3.58%3.12%-0.49%
1 Year PerformanceN/A-4.93%26.30%19.90%

NEXGEL Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NXGLW
NEXGEL
N/A$0.03
+17.1%		N/A-91.9%$0.00$11.27MN/A10
DRTSW
Alpha Tau Medical
N/A$3.78
+2.7%		N/A+1,158.7%$0.00N/AN/A80
ANZUW
Anzu Special Acquisition Corp I
N/A$0.04
-2.3%		N/A-30.8%$0.00N/AN/A2
HSCSW
Heart Test Laboratories
N/A$0.06
+22.6%		N/A-43.5%$0.00$8.67KN/A10
BEATW
HeartBeam
N/A$0.02
+15.3%		N/A-92.4%$0.00N/AN/A5

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:NXGLW) was last updated on 7/14/2026 by MarketBeat.com Staff.
From Our Partners
Trump’s $250 Bill – See Immediately
Former Goldman Sachs VP Dr. David Eifrig is warning that July 28 could trigger the biggest wealth reset in mod...
Stansberry Research | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump Admin to Pump $1 Billion into this “Off-the-Radar” AI Stock
The U.S. government pumped more than $1 billion into Intel. The stock popped 128%. It pumped $400 million into...
InvestorPlace | Sponsoredtc pixel
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...
Weiss Ratings | Sponsoredtc pixel
1 Stock to Own by July 31st
A scheduled announcement on July 31st could reshuffle the stock market's winners and losers - and one lesser-k...
Chaikin Analytics | Sponsoredtc pixel
60 years. Zero competitors.
One company has spent 60 years developing an energy source the International Energy Agency estimates at 140 ti...
Behind the Markets | Sponsoredtc pixel
When I found Rolls-Royce under $2, most people thought I was crazy
In 2022, Karim Rahemtulla recommended Rolls-Royce when it traded under $2. The stock climbed more than 1,100% ...
Monument Traders Alliance | Sponsoredtc pixel
SpaceX Opens Up 11% — Here’s What You Need to Know
SpaceX - ticker SPCX - just completed the biggest IPO in American history, raising $75 billion at a $1.8 trill...
Porter & Company | Sponsoredtc pixel